Company Encyclopedia
View More
name
Marpai
MRAI.US
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services.
328.56 B
MRAI.USMarket value -Rank by Market Cap -/-

Financial Score

23/12/2025 Update
D
Insurance BrokersIndustry
Industry Ranking31/32
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE39.70%A
    • Profit Margin-58.40%E
    • Gross Margin26.60%C
  • Growth ScoreD
    • Revenue YoY-31.65%E
    • Net Profit YoY53.43%B
    • Total Assets YoY-34.96%E
    • Net Assets YoY-21.00%E
  • Cash ScoreE
    • Cash Flow Margin-171.23%D
    • OCF YoY-31.65%E
  • Operating ScoreA
    • Turnover1.28A
  • Debt ScoreE
    • Gearing Ratio361.48%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    16:04 ET MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION

    Marpai, Inc. (OTCQX: MRAI) announced positive momentum for 2026, with a better-than-expected sales cycle and the renewal of its network access agreement with Aetna. The renewal ensures broad access to Aetna's network and introduces the Aetna Faircost Optimizer for cost management. CEO Damien Lamendola highlighted the success of their strategy combining innovative technology with network access.

    prnewswire·
    US
    MRAI
    +3.56%
    prnewswire·
    US
    MRAI
    +3.56%

    Marpai Renews Aetna Network Agreement and Secures Strong 2026 Client Sales

    Marpai Inc. renewed its agreement with the Aetna Signature Administrator PPO network, ensuring broad national provider access for self-funded employer clients. The company reported stronger-than-expected client sales for 2026, surpassing internal expectations. Marpai will also offer the Aetna Faircost Optimizer to manage out-of-network claims costs.

    Reuters·
    US
    MRAI
    +3.56%
    Reuters·
    US
    MRAI
    +3.56%

    Marpai, Inc. Reports Strong Q3 2025 Results

    Marpai, Inc. reported strong Q3 2025 results, highlighting operational and financial improvements. Key metrics include a 24% reduction in operating expenses, a 9% narrowing of operating loss, and a 2% improvement in net loss. The company expanded its client base and improved earnings per share by $0.10. Marpai aims for profitability in Q1 2026, supported by strategic initiatives and a $3.9 million PIPE transaction, indicating confidence in its growth potential.

    Tip Ranks·
    US
    MRAI
    +3.56%
    Tip Ranks·
    US
    MRAI
    +3.56%

    Marpai, Inc. Earnings Call Highlights Mixed Sentiment

    Marpai, Inc.'s Q3 earnings call revealed mixed sentiment, highlighting strategic advancements and financial challenges. The company reported a 24% reduction in operating expenses and a successful $3.9 million capital raise. Despite securing new client deals and operational improvements, Marpai faced a 42% decline in net revenues and ongoing losses. With limited cash reserves, the company aims to enhance financial stability through strategic initiatives, including claims processing consolidation. The earnings call reflects a transitional phase, balancing growth with financial hurdles.

    Tip Ranks·
    US
    MRAI
    +3.56%
    Tip Ranks·
    US
    MRAI
    +3.56%

    Marpai | 10-Q: FY2025 Q3 Revenue: USD 4.037 M

    LB filings·
    US
    MRAI
    +3.56%
    LB filings·
    US
    MRAI
    +3.56%
    © 2025 Longbridge｜Disclaimer